Immunization: Vital Progress, Unfinished Agenda

Overview

Journal Nature

Specialty Science

Date 2019 Nov 8

PMID 31695203

Citations 91

Authors

Peter Piot

Heidi J Larson

Katherine L OBrien

John Nkengasong

Edmond Ng

Samba Sow

Beate Kampmann

Affiliations

Soon will be listed here.

Abstract

Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.

Citing Articles

Lessons for medical countermeasure development from unforeseen outbreaks.

Mura M, Trignol A, Le Dault E, Tournier J Emerg Microbes Infect. 2025; 14(1):2471035.

PMID: 39976365 PMC: 11894751. DOI: 10.1080/22221751.2025.2471035.

Durability of Functional SARS-CoV-2-Specific Immunological Memory and T Cell Response up to 8-9 Months Postrecovery From COVID-19.

Trimbake D, Singh D, K Y, Babar P, S V, Tripathy A J Immunol Res. 2025; 2025:9743866.

PMID: 39963186 PMC: 11832264. DOI: 10.1155/jimr/9743866.

Consequences of post-discharge hospitalisation on the growth of young Bangladeshi children hospitalised with diarrhoea: a secondary case-control analysis of Antibiotics for Children with Diarrhea (ABCD) trial.

Kabir M, Parvin I, Shahid A, Das R, Ackhter M, Alam T J Glob Health. 2025; 15:04039.

PMID: 39946552 PMC: 11893141. DOI: 10.7189/jogh.15.04039.

Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis.

Li Y, Liu Z, Zhou L, Li R Hum Vaccin Immunother. 2025; 21(1):2454076.

PMID: 39902893 PMC: 11796539. DOI: 10.1080/21645515.2025.2454076.

Cancer vaccines: platforms and current progress.

Lei W, Zhou K, Lei Y, Li Q, Zhu H Mol Biomed. 2025; 6(1):3.

PMID: 39789208 PMC: 11717780. DOI: 10.1186/s43556-024-00241-8.

References

Kaslow D, Black S, Bloom D, Datla M, Salisbury D, Rappuoli R . Vaccine candidates for poor nations are going to waste. Nature. 2018; 564(7736):337-339. DOI: 10.1038/d41586-018-07758-3. View

Rappuoli R, Black S, Bloom D . Vaccines and global health: In search of a sustainable model for vaccine development and delivery. Sci Transl Med. 2019; 11(497). DOI: 10.1126/scitranslmed.aaw2888. View

Rappuoli R, Mandl C, Black S, De Gregorio E . Vaccines for the twenty-first century society. Nat Rev Immunol. 2011; 11(12):865-72. PMC: 7098427. DOI: 10.1038/nri3085. View

Orenstein W, Ahmed R . Simply put: Vaccination saves lives. Proc Natl Acad Sci U S A. 2017; 114(16):4031-4033. PMC: 5402432. DOI: 10.1073/pnas.1704507114. View

Hammitt L, Akech D, Morpeth S, Karani A, Kihuha N, Nyongesa S . Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. 2014; 2(7):e397-405. PMC: 5628631. DOI: 10.1016/S2214-109X(14)70224-4. View

Chan J, Nguyen C, Lai J, Dunne E, Andrews R, Blyth C . Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study. BMJ Open. 2018; 8(5):e021512. PMC: 5961565. DOI: 10.1136/bmjopen-2018-021512. View

Guerra F, Bolotin S, Lim G, Heffernan J, Deeks S, Li Y . The basic reproduction number (R) of measles: a systematic review. Lancet Infect Dis. 2017; 17(12):e420-e428. DOI: 10.1016/S1473-3099(17)30307-9. View

Aaby P, Kollmann T, Benn C . Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol. 2014; 15(10):895-9. DOI: 10.1038/ni.2961. View

Wilder-Smith A, Longini I, Zuber P, Barnighausen T, Edmunds W, Dean N . The public health value of vaccines beyond efficacy: methods, measures and outcomes. BMC Med. 2017; 15(1):138. PMC: 5527440. DOI: 10.1186/s12916-017-0911-8. View

10.

Barnighausen T, Bloom D, Cafiero-Fonseca E, OBrien J . Valuing vaccination. Proc Natl Acad Sci U S A. 2014; 111(34):12313-9. PMC: 4151736. DOI: 10.1073/pnas.1400475111. View

11.

Brenzel L . What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?. Vaccine. 2015; 33 Suppl 1:A93-8. DOI: 10.1016/j.vaccine.2014.12.076. View

12.

Zhou F, Shefer A, Wenger J, Messonnier M, Wang L, Lopez A . Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014; 133(4):577-85. DOI: 10.1542/peds.2013-0698. View

13.

Riumallo-Herl C, Chang A, Clark S, Constenla D, Clark A, Brenzel L . Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study. BMJ Glob Health. 2018; 3(2):e000613. PMC: 5898318. DOI: 10.1136/bmjgh-2017-000613. View

14.

Jit M, Hutubessy R, Png M, Sundaram N, Audimulam J, Salim S . The broader economic impact of vaccination: reviewing and appraising the strength of evidence. BMC Med. 2015; 13:209. PMC: 4558933. DOI: 10.1186/s12916-015-0446-9. View

15.

Putri W, Muscatello D, Stockwell M, Newall A . Economic burden of seasonal influenza in the United States. Vaccine. 2018; 36(27):3960-3966. DOI: 10.1016/j.vaccine.2018.05.057. View

16.

Permar S, Levy O, Kollman T, Singh A, De Paris K . Early Life HIV-1 Immunization: Providing a Window for Protection Before Sexual Debut. AIDS Res Hum Retroviruses. 2018; 34(10):823-827. PMC: 6204561. DOI: 10.1089/AID.2018.0018. View

17.

Lee A, Shannon C, Amenyogbe N, Bennike T, Diray-Arce J, Idoko O . Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019; 10(1):1092. PMC: 6414553. DOI: 10.1038/s41467-019-08794-x. View

18.

Madhi S, Dangor Z . Prospects for preventing infant invasive GBS disease through maternal vaccination. Vaccine. 2017; 35(35 Pt A):4457-4460. DOI: 10.1016/j.vaccine.2017.02.025. View

19.

Minh Yen L, Thwaites C . Tetanus. Lancet. 2019; 393(10181):1657-1668. DOI: 10.1016/S0140-6736(18)33131-3. View

20.

Munoz F, Van Damme P, Dinleyici E, Clarke E, Kampmann B, Heath P . The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs. mSphere. 2018; 3(6). PMC: 6222055. DOI: 10.1128/mSphere.00221-18. View